RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Skin Cancer

A collection of news and information related to Skin Cancer published by this site and its partners.

Top Skin Cancer Articles

Displaying items 12-22
  • Spontaneous cancer remission rare, but worth study

    Spontaneous cancer remission rare, but worth study
    In her 28-year career, Dr. Deborah Axelrod says she's had just one patient whose advanced breast cancer inexplicably vanished. The patient, Ann Fonfa, endured multiple surgeries to remove cancerous tumors that kept growing back. All the while, Fonfa...
  • Speak Out

    Baby on board On the way home today, a daycare van full of children ran a red light and cut me off. I called the daycare to report the driver. The response I got was okay, thanks. She didn't seem to care at all. I am sure the parents of those children...
  • Healing waters? It's what the beach life does for us

     Healing waters? It's what the beach life does for us
    Ahhh, the beach. The baking sun, soft sand, cresting waves and sea breeze on your face. There's nothing quite like spending time at South Florida's beaches. Why do we feel so good there? And are the benefits from the beach physical or psychological?...
  • New cancer therapy comes of age, cost a 'toxic' side effect

    MADRID (Reuters) - A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects -- but their high cost is a growing concern. Drugs that help the body's own immune cells fight tumors are expected to be used in...
  • Bristol immune drug shows strong effect in melanoma study

    MADRID (Reuters) - Bristol-Myers Squibb's immunotherapy drug Opdivo produced markedly improved response rates with fewer toxic side effects compared to chemotherapy in a major melanoma study, underscoring its potential as a new treatment option. The data...
  • Roche, GSK melanoma pill combinations look similar in showdown

    MADRID (Reuters) - Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses. The latest findings will fuel...
  • Reducing kids' sun exposure lowers skin cancer risk later in life

    Reducing kids' sun exposure lowers skin cancer risk later in life
    With the warm weather and long days of summer finally here, people are spending more time outdoors. While many people are aware of the need to protect themselves from the sun, reducing children’s exposure to the sun’s harmful ultraviolet (UV)...
  • Bristol immunotherapy gets six month U.S. FDA review for melanoma

    (Reuters) - The U.S. Food and Drug Administration has granted a six-month, priority review to Bristol-Myers Squibb Co's application for immuno-oncology drug Opdivo as a treatment for previously treated melanoma, the company said on Friday. The FDA...
  • FAU gets $600,000 to create Big Data lab

    FAU gets $600,000 to create Big Data lab
    Florida Atlantic University is looking to step into the big leagues of Big Data. The National Science Foundation awarded FAU $600,000 to create a Big Data Training and Research Lab on its Boca Raton campus. The new lab will allow FAU to do work it needs...
  • Florida Hospital surgeon issues call to urgency on skin cancer

    Florida Hospital surgeon issues call to urgency on skin cancer
    There are environmental factors to consider, Rhonda Harmon noted, but also two simple explanations: people love spending time at the beach, and in our culture, some equate beauty with a really great tan. “Most people, I think it’s fair to...
  • FDA approves new drug for melanoma, part of UVA clinical trial

    FDA approves new drug for melanoma, part of UVA clinical trial
    The FDA approved the first in a new class of drugs for better melanoma care, and with applications to other cancers. Read the story here in Modern Healthcare: http://www.modernhealthcare.com/article/20140905/INFO/309059978&utm_source=AltURL&utm_...